Literature DB >> 16675538

Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease.

Jocelyn M Weiss1, Babette S Saltzman, Jennifer A Doherty, Lynda F Voigt, Chu Chen, Shirley A A Beresford, Deirdre A Hill, Noel S Weiss.   

Abstract

There is a wide range of aggressiveness of endometrial tumors, some being indolent and easily treated while others metastasize and prove fatal. The authors used data from three population-based, case-control studies to determine if etiologic factors differ for aggressive disease. Interview data were obtained from 1,304 female residents of western Washington State who were 45-74 years of age and diagnosed with endometrial cancer during 1985-1991, 1994-1995, and 1997-1999 and from 1,779 controls who were of similar ages and selected primarily by random digit dialing. As a means of gauging aggressiveness, tumor characteristics were abstracted from the population-based cancer registry that serves western Washington State. The risk of endometrial cancer among long-term users (> or = 8 years) of unopposed estrogens was particularly high for the least aggressive tumors (odds ratio = 18.6, 95% confidence interval: 12.2, 28.6) but was elevated for moderate and highly aggressive tumors as well (odds ratios = 6.6 and 7.1, respectively). Women who were obese, had a history of diabetes, and had fewer than two children were also at increased risk, regardless of tumor aggressiveness, while oral contraceptive users were at decreased risk of only relatively more aggressive disease. In general, a woman's risk of endometrial cancer appears to be influenced by similar risk factors regardless of disease severity.

Entities:  

Mesh:

Year:  2006        PMID: 16675538     DOI: 10.1093/aje/kwj152

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040.

Authors:  Charles Gaber; Rafael Meza; Julie J Ruterbusch; Michele L Cote
Journal:  J Racial Ethn Health Disparities       Date:  2016-10-17

2.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

3.  Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells.

Authors:  Xin Li; Xiaoping Qi; Lingyin Zhou; Deborah Catera; Neal S Rote; Judith Potashkin; Fadi W Abdul-Karim; George I Gorodeski
Journal:  Gynecol Oncol       Date:  2007-05-04       Impact factor: 5.482

Review 4.  Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.

Authors:  B Long; F W Liu; R E Bristow
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

Review 5.  Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.

Authors:  William V Williams; Louise A Mitchell; S Kathleen Carlson; Kathleen M Raviele
Journal:  Linacre Q       Date:  2019-01-03

6.  Single nucleotide polymorphism of SREBF-1 gene associated with an increased risk of endometrial cancer in Chinese women.

Authors:  Chun-Ping Qiu; Qing-Tao Lv; Samina Dongol; Chenguang Wang; Jie Jiang
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

7.  ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma.

Authors:  A D Marshall; M van Geldermalsen; N J Otte; T Lum; M Vellozzi; A Thoeng; A Pang; R Nagarajah; B Zhang; Q Wang; L Anderson; J E J Rasko; J Holst
Journal:  Oncogenesis       Date:  2017-07-31       Impact factor: 7.485

8.  Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies.

Authors:  Dagfinn Aune; Abhijit Sen; Lars J Vatten
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.